According to this latest study, the 2021 growth of POCT Rapid Diagnostic Reagent will have significant change from previous year. By the most conservative estimates of global POCT Rapid Diagnostic Reagent market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the POCT Rapid Diagnostic Reagent market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of POCT Rapid Diagnostic Reagent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Infectious Disease Detection
Drug Testing
Tumor Marker Detection
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Outpatient
Hospitals
Home Care Settings
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Hologic Inc.
Thermo Fisher Scientific, Inc.
F. Hoffman-La Roche Ltd.
Perkin Elmer, Inc.
Veredus Laboratories
ADT Biotech Sdn Bhd
Zhejiang Orient Gene Biotech Co.,Ltd.
bioMérieux SA
Danaher
Mylab Discovery Solutions Pvt. Ltd.
Neuberg Diagnostics
ALDATU BIOSCIENCES
Quidel Corporation
Quest Diagnostics
Luminex Corporation
Abbott
Guangzhou Wondfo Biotech Co.,Ltd.